{"product_id":"multiple-myeloma-cancer","title":"Multiple Myeloma Cancer","description":"\u003cp\u003eAs the disease progresses, malignant plasma cells accumulate in the bone marrow and produce abnormal proteins known as monoclonal proteins (M proteins). These proteins can cause a range of complications, including kidney damage, bone destruction, and suppression of normal immune function, making patients more vulnerable to infections.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eRisk factors for multiple myeloma include increasing age, male sex, African ancestry, and a personal history of monoclonal gammopathy of undetermined significance (MGUS), a precancerous condition. Exposure to radiation or certain chemicals may also increase risk, although many cases occur without a clearly identifiable cause.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eCommon symptoms include persistent bone pain (especially in the spine or ribs), fatigue due to anemia, frequent infections, unexplained weight loss, and easy bruising or bleeding. Bone damage caused by the disease can lead to fractures, elevated calcium levels in the blood, and reduced mobility.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eDiagnosis typically involves blood and urine tests to detect abnormal proteins, bone marrow biopsy to confirm the presence of malignant plasma cells, and imaging studies such as X-rays, MRI, or PET scans to assess bone involvement. Laboratory findings often include anemia, elevated calcium levels, and kidney dysfunction.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eTreatment depends on disease stage and patient health but often includes combinations of chemotherapy, targeted therapy, immunotherapy, corticosteroids, and stem cell transplantation. Autologous stem cell transplant is a common approach for eligible patients and can help achieve long-term disease control.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eAdvances in treatment have significantly improved survival, particularly with the development of proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies that target specific pathways in myeloma cell growth. Ongoing clinical trials continue to explore new combinations and therapies to further extend remission and improve quality of life.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eLiving with multiple myeloma often involves long-term management rather than a single curative treatment, requiring regular monitoring and supportive care. Patients may need treatments to strengthen bones, manage pain, and prevent infections. With modern therapies and comprehensive care, many individuals are able to achieve prolonged remission and maintain a meaningful quality of life.\u003c\/p\u003e","brand":"IDB Productions","offers":[{"title":"Perfect Bound","offer_id":66873294717232,"sku":"9781776829996","price":12.0,"currency_code":"GBP","in_stock":true}],"url":"https:\/\/www.thegreatbritishbookshop.co.uk\/products\/multiple-myeloma-cancer","provider":"The Great British Bookshop","version":"1.0","type":"link"}